Free Trial
NYSEAMERICAN:ASXC

Asensus Surgical (ASXC) Stock Price, News & Analysis

Asensus Surgical logo
$0.35 0.00 (0.00%)
As of 08/22/2024

About Asensus Surgical Stock (NYSEAMERICAN:ASXC)

Key Stats

Today's Range
$0.35
▼
$0.35
50-Day Range
$0.35
▼
$0.35
52-Week Range
$0.17
▼
$0.40
Volume
N/A
Average Volume
2.03 million shs
Market Capitalization
$94.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Asensus Surgical, Inc. was a medical technology company focused on developing digital and robotic-assisted surgical solutions. The company sought to improve minimally invasive surgery through technology designed to enhance visualization, instrument control, ergonomics, and access to surgical data.

Its principal product was the Senhance Surgical System, a digitally enabled robotic platform intended for laparoscopic procedures. The system incorporated features such as eye-tracking camera control, haptic feedback, reusable instruments, and three-dimensional visualization. Asensus also developed the Intelligent Surgical Unit, which was designed to provide computer-assisted capabilities, including surgical image analysis and procedural support.

The company was founded as TransEnterix and adopted the Asensus Surgical name in 2020. Its products were marketed for use by hospitals and surgeons in the United States, Europe, Japan, and other international markets. Anthony Fernando served as president and chief executive officer during the company’s later operating period. In 2024, Asensus pursued a restructuring and asset transaction involving KARL STORZ, substantially changing the company’s independent operations.

AI Generated. May Contain Errors.

Receive ASXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Asensus Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASXC Stock News Headlines

Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.tc pixel
Durham company could face bankruptcy if $95M sale fails
Biggest stock movers today: NU, K, and more
See More Headlines

ASXC Stock Analysis - Frequently Asked Questions

Asensus Surgical's stock was trading at $0.3479 at the beginning of 2026. Since then, ASXC stock has increased by 0.0% and is now trading at $0.3479.

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) announced its quarterly earnings data on Wednesday, November, 3rd. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.01. The business had revenue of $2.57 million for the quarter, compared to the consensus estimate of $1.02 million. Asensus Surgical had a negative trailing twelve-month return on equity of 184.10% and a negative net margin of 902.25%.

Shares of ASXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Asensus Surgical investors own include Digital Turbine (APPS), CrowdStrike (CRWD), ChargePoint (CHPT), SoFi Technologies (SOFI) and Tesla (TSLA).

Company Calendar

Last Earnings
11/03/2021
Today
10/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSEAMERICAN:ASXC
CIK
N/A
Employees
170
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$78.43 million
Net Margins
-902.25%
Pretax Margin
-899.16%
Return on Equity
-184.10%
Return on Assets
-114.75%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.00
Quick Ratio
0.69

Sales & Book Value

Annual Sales
$8.58 million
Price / Sales
11.04
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
2.68

Miscellaneous

Outstanding Shares
272,330,000
Free Float
264,516,000
Market Cap
$94.74 million
Optionable
Not Optionable
Beta
1.37
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSEAMERICAN:ASXC) was last updated on 10/4/2026 by MarketBeat.com Staff.
From Our Partners